摘要 |
Selective MMP-13 inhibitors are bicyclic pyrimidines of the Formula I or a pharmaceutically acceptable salt thereof, wherein R<SUP>1 </SUP>is hydrogen or alkyl; R<SUP>2</SUP>, R<SUP>3</SUP>, and R<SUP>4 </SUP>include hydrogen, halo, alkyl, C≡C(CH<SUB>2</SUB>)<SUB>m </SUB>aryl, CO<SUB>2 </SUB>alkyl, CO<SUB>2</SUB>(CH<SUB>2</SUB>)<SUB>m </SUB>aryl, COHN alkyl, and CONH(CH<SUB>2</SUB>)<SUB>m </SUB>aryl; and X is O, S, SO, SO<SUB>2</SUB>, CH<SUB>2</SUB>, C-O, CHOH, NH, or NR<SUP>5</SUP>. A compound of Formula I, or a pharmaceutically acceptable salt thereof, is useful for treating cancer or arthritis.
|